Treatment of Graves’ Disease During Pregnancy
نویسنده
چکیده
Graves’ disease is an autoimmune syndrome where thyroid stimulating antibodies bind to and activate the thyrotropin receptor on thyroid cells resulting in hyperthyroidism (Weetman, 2000; Jonklaas, 2011). Specifically, the production of thyroid-stimulating immunoglobulin (TSI) and thyroid-stimulating hormone-binding inhibitory immunoglobulin (TBII) act on the thyroid stimulating hormone receptor to cause thyroid stimulation or thyroid inhibition, respectively.
منابع مشابه
حاملگی پرخطر به علت طوفان تیرویید: گزارش موردی
Background: Graves' disease is the most common cause (85% of all cases) of thyrotoxicosis in women in childbearing age. Many of the symptoms are similar to hyper-metabolic status during pregnancy. The cause of the disease is autoantibodies that stimulate the thyroid-stimulating hormone (TSH) receptor. Hyperthyroidism is uncommon in pregnancy and its prevalence is 0.1-%0.4. In this paper we intr...
متن کاملThyroid-Stimulating Hormone Receptor Antibodies in Pregnancy: Clinical Relevance
Graves' disease is the most common cause of thyrotoxicosis in women of childbearing age. Approximately 1% of pregnant women been treated before, or are being treated during pregnancy for Graves' hyperthyroidism. In pregnancy, as in not pregnant state, thyroid-stimulating hormone (TSH) receptor (TSHR) antibodies (TRAbs) are the pathogenetic hallmark of Graves' disease. TRAbs are heterogeneous fo...
متن کاملPrognostic Factors in the Relapse of Graves’ Disease Following Treatment with Antithy-roid Drugs
Background: Patients with Graves’ disease exhibit a considerable rate of relapse after treatment with antithyroid drugs and require ablative therapy. Objective: The purpose of this study was to evaluate variables which can be used as prognostic factors in predicting the outcome of Graves’ disease after treatment with antithyroid drugs. Methods: Age, sex, duration of antithyroid drug therapy, pr...
متن کاملExogenous Biotin May Be Leading You Astray: A Novel Cause Of Factitious Neonatal Graves’ Disease
Neonatal Graves’ disease is a rare form of pediatric hyperthyroidism that occurs in 1-5% of infants born to mothers with Graves’ disease [1,2]. The risk of neonatal Graves’ disease is highest in those infants born to mothers with active or refractory Graves’ disease during pregnancy. However, infants whose mothers have undergone definitive therapy with either radioiodine ablation or surgical th...
متن کاملComparative frequency of four different types of pregnancy-associated thyrotoxicosis in a single thyroid centre
BACKGROUND Pregnancy and delivery markedly influence thyroid function. However, the comparative prevalence of gestational thyrotoxicosis (GT), new onset of Graves' disease during pregnancy (GD during pregnancy), postpartum destructive thyrotoxicosis (PPT), and postpartum Graves' thyrotoxicosis (PPGD) has not yet been determined. METHODS We prospectively registered and performed a review of 41...
متن کاملI-131 Treatment of Graves' Disease in an Unsuspected First Trimester Pregnancy; the Potential for Adverse Effects on the Fetus and a Review of the Current Guidelines for Pregnancy Screening
Graves' disease is a thyroid-specific autoimmune disorder in which the body makes antibodies to the thyroid-stimulating hormone receptor leading to hyperthyroidism. Therapeutic options for the treatment of Graves' disease include medication, radioactive iodine ablation, and surgery. Radioactive iodine is absolutely contraindicated in pregnancy as exposure to I-131 to the fetal thyroid can resul...
متن کامل